TRV GP V, LLC
Follow13F filer, CIK 1990717, Boston, MA
TRV GP V, LLC reported $474,980,000 across 4 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16.
Accepted , ingested 13F-HR 0001193125-26-463550
- Period
- 2026-09-30
- Reported value
- $475M
- Holdings
- 4
- Top 10 weight
- 100%
- New
- 1
- Sold out
- 0
Part of the filer group Third Rock Ventures VI, L.P.
TRV GP VI, LLCThird Rock Ventures GP IV, L.P.
- TRV GP VI, LLC
- Third Rock Ventures GP IV, L.P.
- Third Rock Ventures GP V, L.P.
- Third Rock Ventures GP VI, L.P.
- Third Rock Ventures GP V, LP
- Third Rock Ventures IV, L.P.
- Third Rock Ventures VI, L.P.
- Third Rock Ventures V, L.P.
Stakes and trades reported after 2026-09-30
13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.
- TCXB TCGX ACQUISITION CORP II: 13G 990,000 shares, 9.5% of the class, 13G filed 2026-10-26, 0001193125-26-432002Timeline
Accepted , ingested
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| LSTAnew | +455,192 | $655K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| SEPNreduced | -147,200 | -$5.76M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0001193125-26-463550, largest first. % of portfolio is the value over $474,980,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| SEPNSEPTERNA INC | 6,068,391 | $237M | 49.99% | -147,200 | Timeline | ||
| RAPPRAPPORT THERAPEUTICS INC | 6,280,525 | $211M | 44.43% | 0 | 2026-10-30, Form 4: granted 238,095 shares on 2026-10-30 | Timeline | |
| MAZEMAZE THERAPEUTICS INC | 950,800 | $25.8M | 5.44% | 0 | Timeline | ||
| LSTALISATA THERAPEUTICS INC | 455,192 | $655K | 0.14% | new | Timeline |
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001193125-26-463550 | base | 2026-11-16 |